- Home
- DTST vs KTTA Comparison
DTST vs KTTA Comparison
Compare DTST & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DTST | KTTA |
|---|---|---|
| Founded | 2001 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 26.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | DTST | KTTA |
|---|---|---|
| Price | $4.29 | $0.70 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 20.0K | ★ 146.6K |
| Earning Date | 03-30-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8036.56 | N/A |
| EPS | ★ 1.89 | N/A |
| Revenue | ★ $25,529,819.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.35 | ★ N/A |
| Revenue Growth | ★ 260.19 | N/A |
| 52 Week Low | $2.93 | $0.28 |
| 52 Week High | $5.44 | $3.79 |
Technical Indicators
Market Signals| Indicator | DTST | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 27.74 |
| Support Level | $4.10 | $0.71 |
| Resistance Level | $4.95 | $0.75 |
| Average True Range (ATR) | 0.27 | 0.05 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 35.88 | 8.29 |
Price Performance
Historical ComparisonAbout DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).